Nutrients and the microenvironment to feed a T cell army

Seminars in Immunology

Volumn 28, Issue 5, 2016, Pages 505-513

  Johnson, Marc O ^a   Siska, Peter J ^a   Contreras, Diana C ^a   Rathmell, Jeffrey C ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Circadian rhythms; Epigenetics; Glut1; Glutamine; mTOR; T cell metabolism

Indexed keywords

ADENYLATE KINASE; GLUTAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MYC PROTEIN; GLUCOSE;

CELL GROWTH; CELL METABOLISM; CIRCADIAN RHYTHM; EPIGENETICS; GLUCOSE TRANSPORT; HUMAN; LYMPHOCYTE FUNCTION; METABOLIC REGULATION; MICROENVIRONMENT; NONHUMAN; NUTRIENT; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE; ADAPTATION; ANIMAL; BIOLOGICAL RHYTHM; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR MICROENVIRONMENT;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BIOLOGICAL CLOCKS; CELLULAR MICROENVIRONMENT; ENERGY METABOLISM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GLUCOSE; GLUTAMINE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASMS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 85000836766     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2016.09.003     Document Type: Review

References (115)

1. [1] EL-GABALAWY, H., GUENTHER, L.C., BERNSTEIN, C.N., Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J. Rheumatol. 85 (2010), 2–10.
2. [2] Wang, R., Dillon, C.P., Shi, L.Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L.L., Fitzgerald, P., Chi, H., Munger, J., Green, D.R., The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35:6 (2011), 871–882.
3. [3] Greiner, E.F., Guppy, M., Brand, K., Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J. Biol. Chem. 269:50 (1994), 31484–31490.
4. [4] House, S.W., Warburg, O., Burk, D., Schade, A.L., On respiratory impairment in cancer cells. Science 124:3215 (1956), 267–272.
5. [5] Wang, T., Marquardt, C., Foker, J., Aerobic glycolysis during lymphocyte proliferation. Nature 261:5562 (1976), 702–705.
6. [6] Wise, D.R., Thompson, C.B., Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 35:8 (2010), 427–433.
7. [7] Besedovsky, L., Born, J., Lange, T., Endogenous glucocorticoid receptor signaling drives rhythmic changes in human T-cell subset numbers and the expression of the chemokine receptor CXCR4. FASEB J. 28:1 (2014), 67–75.
8. [8] Karlsson, B.H., Knutsson, A.K., Lindahl, B.O., Alfredsson, L.S., Metabolic disturbances in male workers with rotating three-shift work. Results of the WOLF study. Int. Arch. Occup. Environ. Health 6:6 (2003), 424–430.
9. [9] Karlsson, B., Knutsson, A., Lindahl, B., Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27, 485 people. Occup. Environ. Med. 58:11 (2001), 747–752.
10. [10] Froy, O., The relationship between nutrition and circadian rhythms in mammals. Front. Neuroendocrinol. 28:2-3 (2007), 61–71.
11. [11] Dimitrov, S., Benedict, C., Heutling, D., Westermann, J., Born, J., Lange, T., Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood 113:21 (2009), 5134–5143.
12. [12] Masopust, D., Vezys, V., Marzo, A.L., Lefrançois, L., Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:5512 (2001), 2413–2417.
13. [13] von Andrian, U.H., Mackay, C.R., T-Cell function and migration—two sides of the same coin. New Engl. J. Med. 343:14 (2000), 1020–1034.
14. [14] Chang, C.H., Curtis, J.D., Maggi, L.B. Jr., Faubert, B., Villarino, A.V., O'Sullivan, D., Huang, S.C., van der Windt, G.J., Blagih, J., Qiu, J., Weber, J.D., Pearce, E.J., Jones, R.G., Pearce, E.L., Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153:6 (2013), 1239–1251.
15. [15] Buck, M.D., O'sullivan, D., Pearce, E.L., T cell metabolism drives immunity. J. Exp. Med. 212:9 (2015), 1345–1360.
16. [16] Carr, E.L., Kelman, A., Wu, G.S., Gopaul, R., Senkevitch, E., Aghvanyan, A., Turay, A.M., Frauwirth, K.A., Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J. Immunol. 185:2 (2010), 1037–1044.
17. [17] Sinclair, L.V., Rolf, J., Emslie, E., Shi, Y.B., Taylor, P.M., Cantrell, D.A., Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14:5 (2013), 500–508.
18. [18] Alves, N.L., Derks, I.A.M., Berk, E., Spijker, R., van Lier, R.A.W., Eldering, E., The noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity 24:6 (2016), 703–716.
19. [19] Hosios, A.M., Hecht, V.C., Danai, L.V., Johnson, M.O., Rathmell, J.C., Steinhauser, M.L., Manalis, S.R., Vander Heiden, M.G., Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev. Cell 36:5 (2016), 540–549.
20. [20] Sukumar, M., Liu, J., Ji, Y., Subramanian, M., Crompton, J.G., Yu, Z., Roychoudhuri, R., Palmer, D.C., Muranski, P., Karoly, E.D., Mohney, R.P., Klebanoff, C.A., Lal, A., Finkel, T., Restifo, N.P., Gattinoni, L., Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest. 123:10 (2016), 4479–4488.
21. [21] van der Windt, Gerritje J.W., Everts, B., Chang, C.-H., Curtis, Jonathan D., Freitas, Tori C., Amiel, E., Pearce, Edward J., Pearce, Erika L., Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36:1 (2012), 68–78.
22. [22] MacIver, N.J., Michalek, R.D., Rathmell, J.C., Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31 (2013), 259–283.
23. [23] Lukens, J., Dixit, V.D., Kanneganti, T.-D., Inflammasome activation in obesity-related inflammatory diseases and autoimmunity. Discov. Med. 12:62 (2011), 65–74.
24. [24] Yang, H., Youm, Y.-H., Vandanmagsar, B., Ravussin, A., Gimble, J.M., Greenway, F., Stephens, J.M., Mynatt, R.L., Dixit, V.D., Obesity increases the production of proinflammatory mediators from adipose tissue t cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J. Immunol. Baltim. Md.: 1950 185:3 (2010), 1836–1845.
25. [25] Ramakrishnan, P., Kahn, D.A., Baltimore, D., Anti-apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cells. Cell Death Differ. 18:4 (2011), 690–699.
26. [26] McGeachy, M.J., Stephens, L.A., Anderton, S.M., Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4 + CD25+ regulatory cells within the central nervous system. J. Immunol. 175:5 (2005), 3025–3032.
27. [27] Selvaraj, R.K., Geiger, T.L., Mitigation of experimental allergic encephalomyelitis by TGF-β induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance. J. Immunol. 180:5 (2008), 2830–2838.
28. [28] Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D., Debré, P., Piette, J.-C., Gorochov, G., Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 75:12 (2005), 8392–8400.
29. [29] Yang, J., Chu, Y., Yang, X., Gao, D., Zhu, L., Yang, X., Wan, L., Li, M., Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheumatism 60:5 (2009), 1472–1483.
30. [30] Marabelle, A., lien, xE, Kohrt, H., Sagiv-Barfi, I., Ajami, B., Axtell, R.C., Zhou, G., Rajapaksa, R., Green, M.R., Torchia, J., Brody, J., Luong, R., Rosenblum, M.D., Steinman, L., Levitsky, H.I., Tse, V., Levy, R., Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J. Clin. Invest. 123:6 (2016), 2447–2463.
31. [31] Hegazy, A.N., Peine, M., Helmstetter, C., Panse, I., Fröhlich, A., Bergthaler, A., Flatz, L., Pinschewer, D.D., Radbruch, A., Löhning, M., Interferons direct th2 cell reprogramming to generate a stable GATA-3 + T-bet+ cell subset with combined Th2 and Th1 cell functions. Immunity 32:1 (2010), 116–128.
32. [32] Shi, G., Cox, C.A., Vistica, B.P., Tan, C., Wawrousek, E.F., Gery, I., Phenotype switching by inflammation-inducing polarized Th17Cells, but not by Th1Cells. J. Immunol. Baltim. Md.: 1950 181:10 (2008), 7205–7213.
33. [33] Zhou, L., Chong, M.M.W., Littman, D.R., Plasticity of CD4+ T cell lineage differentiation. Immunity 30:5 (2009), 646–655.
34. [34] Koenen, H.J.P.M., Smeets, R.L., Vink, P.M., van Rijssen, E., Boots, A.M.H., Joosten, I., Human CD25highFoxp3pos regulatory T cells differentiate into IL-17—producing cells. Blood 112:6 (2008), 2340–2352.
35. [35] Spiegelman, B.M., Flier, J.S., Obesity and the regulation of energy balance. Cell 104:4 (2001), 531–543.
36. [36] Dang, C.V., Kim, J.-w., Gao, P., Yustein, J., The interplay between MYC and HIF in cancer. Nat. Rev. Cancer 8:1 (2008), 51–56.
37. [37] Laplante, M., Sabatini, David M., mTOR signaling in growth control and disease. Cell 149:2 (2012), 274–293.
38. [38] O'Neill, H.M., Holloway, G.P., Steinberg, G.R., AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity. Mol. Cell. Endocrinol. 366:2 (2013), 135–151.
39. [39] Hardie, D.G., Hawley, S.A., Scott, J.W., AMP-activated protein kinase−development of the energy sensor concept. J. Physiol. 574:Pt 1 (2006), 7–15.
40. [40] Inoki, K., Zhu, T., Guan, K.-L., TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:5 (2003), 577–590.
41. [41] Porstmann, T., Santos, C.R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J.R., Chung, Y.-L., Schulze, A., SREBP activity is regulated by mTORC1 and contributes to akt-Dependent cell growth. Cell Metab. 8:3–3 (2008), 224–236.
42. [42] Delgoffe, G.M., Kole, T.P., Zheng, Y., Zarek, P.E., Matthews, K.L., Xiao, B., Worley, P.F., Kozma, S.C., Powell, J.D., The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30:6 (2009), 832–844.
43. [43] Zeng, H., Yang, K., Cloer, C., Neale, G., Vogel, P., Chi, H., mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 499:7459 (2013), 485–490.
44. [44] Huynh, A., DuPage, M., Priyadharshini, B., Sage, P.T., Quiros, J., Borges, C.M., Townamchai, N., Gerriets, V.A., Rathmell, J.C., Sharpe, A.H., Bluestone, J.A., Turka, L.A., Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat. Immunol. 16:2 (2015), 188–196.
45. [45] Delgoffe, G.M., Pollizzi, K.N., Waickman, A.T., Heikamp, E., Meyers, D.J., Horton, M.R., Xiao, B., Worley, P.F., Powell, J.D., The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12:4 (2011), 295–303.
46. [46] Verbist, K.C., Guy, C.S., Milasta, S., Liedmann, S., Kamiński, M.M., Wang, R., Green, D.R., Metabolic maintenance of cell asymmetry following division in activated T lymphocytes. Nature 532:7599 (2016), 389–393.
47. [47] Procaccini, C., De Rosa, V., Galgani, M., Abanni, L., Calì, G., Porcellini, A., Carbone, F., Fontana, S., Horvath, T.L., La Cava, A., Matarese, G., An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33:6 (2010), 929–941.
48. [48] Huynh, A., DuPage, M., Priyadharshini, B., Sage, P.T., Quiros, J., Borges, C.M., Townamchai, N., Gerriets, V.A., Rathmell, J.C., Sharpe, A.H., Bluestone, J.A., Turka, L.A., The phosphatase PTEN-mediated control of PI-3 kinase in T(regs) cells maintains homeostasis and lineage stability. Nat. Immunol. 16:2 (2015), 188–196.
49. [49] Shrestha, S., Yang, K., Guy, C., Vogel, P., Neale, G., Chi, H., Regulatory T cells require the phosphatase PTEN to restrain type 1 and follicular helper T-cell responses. Nat. Immunol. 16:2 (2015), 178–187.
50. [50] Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458 (2009), 762–765.
51. [51] Eilers, M., Eisenman, R.N., Myc's broad reach. Genes. Dev. 22:20 (2008), 2755–2766.
52. [52] O'Connell, B.C., Cheung, A.F., Simkevich, C.P., Tam, W., Ren, X., Mateyak, M.K., Sedivy, J.M., A large scale genetic analysis of c-Myc-regulated gene expression patterns. J. Biol. Chem. 278:14 (2003), 12563–12573.
53. [53] Wang, R., Green, D.R., Metabolic reprogramming and metabolic dependency in T cells. Immunol. Rev. 249:1 (2012), 14–26.
54. [54] Hudson, C.C., Liu, M., Chiang, G.G., Otterness, D.M., Loomis, D.C., Kaper, F., Giaccia, A.J., Abraham, R.T., Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin. Mol. Cell. Biol. 22:20 (2002), 7004–7014.
55. [55] Seagroves, T.N., Ryan, H.E., Lu, H., Wouters, B.G., Knapp, M., Thibault, P., Laderoute, K., Johnson, R.S., Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol. Cell. Biol. 21:10 (2001), 3436–3444.
56. [56] Kojima, H., Gu, H., Nomura, S., Caldwell, C.C., Kobata, T., Carmeliet, P., Semenza, G.L., Sitkovsky, M.V., Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice. Proc. Natl. Acad. Sci. 99:4 (2002), 2170–2174.
57. [57] Shi, L.Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D.R., Chi, H., HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of T(H)17 and T(reg) cells. J. Exp. Med. 208:7 (2011), 1367–1376.
58. [58] Dang, Eric V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., Luo, W., Zeller, K., Shimoda, L., Topalian, Suzanne L., Semenza, Gregg L., Dang, Chi V., Pardoll, Drew M., Pan, F., Control of TH17/Treg balance by hypoxia-Inducible factor 1. Cell 146:5 (2011), 772–784.
59. [59] Bonafé, N., Gilmore-Hebert, M., Folk, N.L., Azodi, M., Zhou, Y., Chambers, S.K., Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3é untranslated region of colony-stimulating Factor–1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype. Cancer Res. 65:9 (2005), 3762–3771.
60. [60] Ho, P.-C., Bihuniak, Jessica D., Macintyre, Andrew N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, Jose C., Kleinstein, Steven H., Abel, E.D., Insogna, Karl L., Feske, S., Locasale, Jason W., Bosenberg, Marcus W., Rathmell, Jeffrey C., Kaech, Susan M., Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor t cell responses. Cell 162:6 (2015), 1217–1228.
61. [61] Macintyre, A.N., Gerriets, V.A., Nichols, A.G., Michalek, R.D., Rudolph, M.C., Deoliveira, D., Anderson, S.M., Abel, E.D., Chen, B.J., Hale, L.P., Rathmell, J.C., The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20:1 (2014), 61–72.
62. [62] Nakaya, M., Xiao, Y., Zhou, X., Chang, J.H., Chang, M., Cheng, X., Blonska, M., Lin, X., Sun, S.C., Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 40:5 (2014), 692–705.
63. [63] Murray, C.M., Hutchinson, R., Bantick, J.R., Belfield, G.P., Benjamin, A.D., Brazma, D., Bundick, R.V., Cook, I.D., Craggs, R.I., Edwards, S., Evans, L.R., Harrison, R., Holness, E., Jackson, A.P., Jackson, C.G., Kingston, L.P., Perry, M.W.D., Ross, A.R.J., Rugman, P.A., Sidhu, S.S., Sullivan, M., Taylor-Fishwick, D.A., Walker, P.C., Whitehead, Y.M., Wilkinson, D.J., Wright, A., Donald, D.K., Monocarboxylate transporter MCT1 is a target for immunosuppression. Nat. Chem. Biol. 1:7 (2005), 371–376.
64. [64] Jacobs, S.R., Herman, C.E., MacIver, N.J., Wofford, J.A., Wieman, H.L., Hammen, J.J., Rathmell, J.C., Glucose uptake is limiting in T cell activation and requires CD28-mediated akt-dependent and independent pathways. J. Immunol. Baltim. Md.: 195) 180:7 (2008), 4476–4486.
65. [65] Michalek, R.D., Gerriets, V.A., Jacobs, S.R., Macintyre, A.N., MacIver, N.J., Mason, E.F., Sullivan, S.A., Nichols, A.G., Rathmell, J.C., Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186:6 (2011), 3299–3303.
66. [66] Neildez-Nguyen, T.M.A., Bigot, J., Da Rocha, S., Corre, G., Boisgerault, F., Paldi, A., Galy, A., Hypoxic culture conditions enhance the generation of regulatory T cells. Immunology 144:3 (2015), 431–443.
67. [67] Newsholme, P., Procopio, J., Lima, M.M.R., Pithon-Curi, T.C., Curi, R., Glutamine and glutamate—their central role in cell metabolism and function. Cell Biochem. Funct. 21:1 (2003), 1–9.
68. [68] Cheng, R.J.D., Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29 (2009), 313–324.
69. [69] Cheng, T., Sudderth, J., Yang, C., Mullen, A.R., Jin, E.S., Matés, J.M., DeBerardinis, R.J., Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 8674–8679.
70. [70] Yang, C., Ko, B., Hensley, C.T., Jiang, L., Wasti, A.T., Kim, J., Sudderth, J., Calvaruso, M.A., Lumata, L., Mitsche, M., Rutter, J., Merritt, M.E., DeBerardinis, R.J., Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol. Cell 56:3 (2014), 414–424.
71. [71] Pochini, L., Scalise, M., Galluccio, M., Indiveri, C., Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health. Front. Chem., 2, 2014, 61.
72. [72] Peng, M., Yin, N., Li, Ming O., Sestrins function as guanine nucleotide dissociation inhibitors for rag GTPases to control mTORC1 signaling. Cell 159:1 (2014), 122–133.
73. [73] Chantranupong, L., Scaria, Sonia M., Saxton, Robert A., Gygi, Melanie P., Shen, K., Wyant, Gregory A., Wang, T., Harper, J.W., Gygi, Steven P., Sabatini, David M., The CASTOR proteins are arginine sensors for the mTORC1 pathway. Cell 165:1 (2016), 153–164.
74. [74] Poncet, N., Mitchell, F.E., Ibrahim, A.F.M., McGuire, V.A., English, G., Arthur, J.S.C., Shi, Y.-B., Taylor, P.M., The catalytic subunit of the system L1 amino acid transporter (Slc7a5) facilitates nutrient signalling in mouse skeletal muscle. PLoS One, 9(2), 2014, e89547.
75. [75] Jones, P.A., Takai, D., The role of DNA methylation in mammalian epigenetics. Science 293:5532 (2001), 1068–1070.
76. [76] Niculescu, M.D., Zeisel, S.H., Diet, methyl donors and D.N.A. methylation: interactions between dietary folate, methionine and choline. J. Nutr. 132:8 (2002), 2333S–2335S.
77. [77] Trerotola, M., Relli, V., Simeone, P., Alberti, S., Epigenetic inheritance and the missing heritability. Hum. Genomics, 9(1), 2015, 17.
78. [78] Mentch, Samantha J., Mehrmohamadi, M., Huang, L., Liu, X., Gupta, D., Mattocks, D., Gómez Padilla, P., Ables, G., Bamman, Marcas M., Thalacker-Mercer, Anna E., Nichenametla, Sailendra N., Locasale, Jason W., Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism. Cell Metab. 22:5 (2016), 861–873.
79. [79] Nakajima, H., Kunimoto, H., TET2 as an epigenetic master regulator for normal and malignant hematopoiesis. Cancer Sci. 105:9 (2014), 1093–1099.
80. [80] Lee, Joyce V., Carrer, A., Shah, S., Snyder, Nathaniel W., Wei, S., Venneti, S., Worth, Andrew J., Yuan, Z.-F., Lim, H.-W., Liu, S., Jackson, E., Aiello, Nicole M., Haas, Naomi B., Rebbeck, Timothy R., Judkins, A., Won, K.-J., Chodosh, Lewis A., Garcia, Benjamin A., Stanger, Ben Z., Feldman, Michael D., Blair, Ian A., Wellen, Kathryn E., Akt-Dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20:2 (2016), 306–319.
81. [81] Choudhary, C., Weinert, B.T., Nishida, Y., Verdin, E., Mann, M., The growing landscape of lysine acetylation links metabolism and cell signalling. Nat. Rev. Mol. Cell Biol. 15:8 (2014), 536–550.
82. [82] van Loosdregt, J., Vercoulen, Y., Guichelaar, T., Gent, Y.Y.J., Beekman, J.M., van Beekum, O., Brenkman, A.B., Hijnen, D.-J., Mutis, T., Kalkhoven, E., Prakken, B.J., Coffer, P.J., Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115:5 (2010), 965–974.
83. [83] Balmer, Maria L., Ma, Eric H., Bantug, Glenn R., Grählert, J., Pfister, S., Glatter, T., Jauch, A., Dimeloe, S., Slack, E., Dehio, P., Krzyzaniak, Magdalena A., King, Carolyn G., Burgener, A.-V., Fischer, M., Develioglu, L., Belle, R., Recher, M., Bonilla, Weldy V., Macpherson, Andrew J., Hapfelmeier, S., Jones, Russell G., Hess, C., Memory C+ T cells require increased concentrations of acetate induced by stress for optimal function. Immunity, 2016, D8.
84. [84] Prendergast, G., Ziff, E., Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251:4990 (1991), 186–189.
85. [85] Tserel, L., Kolde, R., Limbach, M., Tretyakov, K., Kasela, S., Kisand, K., Saare, M., Vilo, J., Metspalu, A., Milani, L., Peterson, P., Age-related profiling of DNA methylation in CD8+ T cells reveals changes in immune response and transcriptional regulator genes. Sci. Rep., 5, 2015, 13107.
86. [86] Jones, B., Chen, J., Inhibition of IFN-γ transcription by site-specific methylation during T helper cell development. The EMBO Journal 25:11 (2006), 2443–2452.
87. [87] Yano, S., Ghosh, P., Kusaba, H., Buchholz, M., Longo, D.L., Effect of promoter methylation on the regulation of IFN-γ gene during In vitro differentiation of human peripheral blood T cells into a th2 population. J. Immunol. 171:5 (2003), 2510–2516.
88. [88] Lee, P.P., Fitzpatrick, D.R., Beard, C., Jessup, H.K., Lehar, S., Makar, K.W., Pérez-Melgosa, M., Sweetser, M.T., Schlissel, M.S., Nguyen, S., Cherry, S.R., Tsai, J.H., Tucker, S.M., Weaver, W.M., Kelso, A., Jaenisch, R., Wilson, C.B., A critical role for dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15:5 (2001), 763–774.
89. [89] Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K., Chang, H.-D., Bopp, T., Schmitt, E., Klein-Hessling, S., Serfling, E., Hamann, A., Huehn, J., Epigenetic control of the foxp3 locus in regulatory t cells. PLoS Biol., 5(2), 2007, e38.
90. [90] Gray, S.M., Kaech, S.M., Staron, M.M., The interface between transcriptional and epigenetic control of effector and memory CD8(+) T-cell differentiation. Immunol. Rev. 261:1 (2014), 157–168.
91. [91] Chang, S., Collins, P.L., Aune, T.M., T-Bet dependent removal of sin3A-histone deacetylase complexes at the ifng locus drives th1 differentiation. J. Immunol. Baltim. Md.: 1950 181:12 (2008), 8372–8381.
92. [92] Ye, J., Kumanova, M., Hart, L.S., Sloane, K., Zhang, H., De Panis, D.N., Bobrovnikova-Marjon, E., Diehl, J.A., Ron, D., Koumenis, C., The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J. 29:12 (2010), 2082–2096.
93. [93] Romero-Garcia, S., Moreno-Altamirano, M.M.B., Prado-Garcia, H., Sánchez-García, F.J., Lactate contribution to the tumor microenvironment: mechanisms effects on immune cells and therapeutic relevance. Front. Immunol., 7, 2016, 52.
94. [94] Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., Renner, K., Timischl, B., Mackensen, A., Kunz-Schughart, L., Andreesen, R., Krause, S.W., Kreutz, M., Inhibitory effect of tumor cell–derived lactic acid on human T cells. Blood 109:9 (2007), 3812–3819.
95. [95] Ottensmeier, C.H., Perry, K.L., Harden, E.L., Stasakova, J., Jenei, V., Fleming, J., Wood, O., Woo, J., Woelk, C.H., Thomas, G.J., Thirdborough, S.M., Upregulated glucose metabolism correlates inversely with CD8+ T cell infiltration and survival in squamous cell carcinoma. Cancer Res., 2016.
96. [96] Jiang, Y., Li, Y., Zhu, B., T-cell exhaustion in the tumor microenvironment. Cell. Death. Dis., 6, 2015, e1792.
97. [97] Zheng, Y., Delgoffe, G.M., Meyer, C.F., Chan, W., Powell, J.D., Anergic T cells are metabolically anergic. J. Immunol. Baltim. Md.: 1950 183:10 (2009), 6095–6101.
98. [98] Parry, R.V., Chemnitz, J.M., Frauwirth, K.A., Lanfranco, A.R., Braunstein, I., Kobayashi, S.V., Linsley, P.S., Thompson, C.B., Riley, J.L., CTLA-4 and PD-1 receptors inhibit T-Cell activation by distinct mechanisms. Mol. Cell. Biol. 5:21 (2005), 9543–9553.
99. [99] Probst, H.C., McCoy, K., Okazaki, T., Honjo, T., van den Broek, M., Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6:3 (2005), 280–286.
100. [100] Chang, C.-H., Qiu, J., O'sullivan, D., Buck, Michael D., Noguchi, T., Curtis, Jonathan D., Chen, Q., Gindin, M., Gubin, Matthew M., van der Windt, Gerritje J.W., Tonc, E., Schreiber, Robert D., Pearce, Edward J., Pearce, Erika L., Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162:6 (2015), 1229–1241.
101. [101] Blackburn, S.D., Shin, H., Freeman, G.J., Wherry, E.J., Selective expansion of a subset of exhausted CD8T cells by αPD-L1 blockade. Proc. Natl. Acad. Sci. 105:39 (2008), 15016–15021.
102. [102] Patsoukis, N., Bardhan, K., Chatterjee, P., Sari, D., Liu, B., Bell, L.N., Karoly, E.D., Freeman, G.J., Petkova, V., Seth, P., Li, L., Boussiotis, V.A., PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat. Commun., 6, 2015.
103. [103] Siska, P.J., Rathmell, J.C., T cell metabolic fitness in antitumor immunity. Trends Immunol. 36:4 (2015), 257–264.
104. [104] Bell-Pedersen, D., Cassone, V.M., Earnest, D.J., Golden, S.S., Hardin, P.E., Thomas, T.L., Zoran, M.J., Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat. Rev. Genet. 6:7 (2005), 544–556.
105. [105] Scheiermann, C., Kunisaki, Y., Frenette, P.S., Circadian control of the immune system. Nat. Rev. Immunol. 13:3 (2013), 190–198.
106. [106] Qian, J., Scheer, F.A.J.L., Circadian system and glucose metabolism: implications for physiology and disease. Trends Endocrinol. Metab. 27:5 (2016), 282–293.
107. [107] Takahashi, J.S., Hong, H.-K., Ko, C.H., McDearmon, E.L., The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat. Rev. Genet. 9:10 (2008), 764–775.
108. [108] Paschos, G.K., Ibrahim, S., Song, W.-L., Kunieda, T., Grant, G., Reyes, T.M., Bradfield, C.A., Vaughan, C.H., Eiden, M., Masoodi, M., Griffin, J.L., Wang, F., Lawson, J.A., FitzGerald, G.A., Obesity in mice with adipocyte-specific deletion of clock component Arntl. Nat. Med. 18:12 (2012), 1768–1777.
109. [109] Dibner, C., Schibler, U., Albrecht, U., The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu. Rev. Physiol. 72:1 (2010), 517–549.
110. [110] Boivin, D.B., James, F.O., Wu, A., Cho-Park, P.F., Xiong, H., Sun, Z.S., Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 102:12 (2003), 4143–4145.
111. [111] Ando, N., Nakamura, Y., Aoki, R., Ishimaru, K., Ogawa, H., Okumura, K., Shibata, S., Shimada, S., Nakao, A., Circadian gene clock regulates psoriasis-like skin inflammation in mice. J. Invest. Dermatol. 135:12 (2015), 3001–3008.
112. [112] Marciano, David P., Chang, Mi R., Corzo, Cesar A., Goswami, D., Lam, Vinh Q., Pascal, Bruce D., Griffin, Patrick R., The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARγ, RORs, and rev-erbs. Cell Metab. 19:2 (2014), 193–208.
113. [113] Bugge, A., Feng, D., Everett, L.J., Briggs, E.R., Mullican, S.E., Wang, F., Jager, J., Lazar, M.A., Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. Genes. Dev. 26:7 (2012), 657–667.
114. [114] Altman, Brian J., Hsieh, Annie L., Sengupta, A., Krishnanaiah, Saikumari Y., Stine, Zachary E., Walton, Zandra E., Gouw, Arvin M., Venkataraman, A., Li, B., Goraksha-Hicks, P., Diskin, Sharon J., Bellovin, David I., Simon, M.C., Rathmell, Jeffrey C., Lazar, Mitchell A., Maris, John M., Felsher, Dean W., Hogenesch, John B., Weljie, Aalim M., Dang, Chi V., MYC disrupts the circadian clock and metabolism in cancer cells. Cell Metab. 22:6 (2015), 1009–1019.
115. [115] Hemmers, S., Rudensky, Alexander Y., The cell-intrinsic circadian clock is dispensable for lymphocyte differentiation and function. Cell Rep. 11:9 (2015), 1339–1349.